Glenmede Trust Co. NA Has $17.52 Million Holdings in Aflac Incorporated (NYSE:AFL)

Glenmede Trust Co. NA decreased its position in shares of Aflac Incorporated (NYSE:AFL) by 16.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 156,742 shares of the financial services provider’s stock after selling 31,508 shares during the quarter. Glenmede Trust Co. NA’s holdings in Aflac were worth $17,524,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of AFL. Spinnaker Trust boosted its stake in Aflac by 2.7% during the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock valued at $405,000 after purchasing an additional 95 shares during the last quarter. Secure Asset Management LLC boosted its position in shares of Aflac by 1.0% during the third quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider’s stock valued at $1,094,000 after buying an additional 96 shares during the last quarter. Ascent Group LLC grew its holdings in Aflac by 0.6% during the second quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider’s stock worth $1,539,000 after buying an additional 99 shares in the last quarter. Ieq Capital LLC raised its position in Aflac by 0.5% in the 2nd quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider’s stock valued at $1,945,000 after buying an additional 101 shares during the last quarter. Finally, New Century Financial Group LLC raised its position in Aflac by 2.5% in the 3rd quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock valued at $469,000 after buying an additional 101 shares during the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Stock Up 0.1 %

AFL stock opened at $114.10 on Friday. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The stock has a fifty day moving average of $111.11 and a 200-day moving average of $101.23. The company has a market capitalization of $63.39 billion, a price-to-earnings ratio of 17.18, a PEG ratio of 2.18 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. During the same quarter last year, the business earned $1.84 earnings per share. The company’s quarterly revenue was down 40.4% on a year-over-year basis. As a group, equities research analysts predict that Aflac Incorporated will post 7.22 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.75%. Aflac’s payout ratio is 30.12%.

Analysts Set New Price Targets

Several research firms have recently issued reports on AFL. Evercore ISI upped their target price on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research note on Thursday, September 26th. UBS Group upped their price objective on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 14th. JPMorgan Chase & Co. lifted their target price on shares of Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, October 3rd. Morgan Stanley upped their target price on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Finally, Truist Financial increased their price target on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $97.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.